Assessing Tolerability of Avonex Intramuscular Injections

Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle

The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.

Inclusion Criteria:

• Between 18 - 65 years of age;
• Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
• Currently being treated with Avonex® for at least 90 days;
• Using 25 gauge needles for injection of Avonex® for at least 90 days;
• Willing and able to complete study questionnaires; and
• Provided informed consent to participate in this study

Exclusion Criteria:

• Diagnosis of Progressive Multiple Sclerosis;
• History of recent illness or infection;
• History of allergic reaction to Avonex®;
• Any prior usage of a 30 gauge needle for administration of Avonex®;
• Concurrent treatment with other immunomodulating therapies;
• Pregnant or planning on becoming pregnant;
• Nursing mothers; and
• Unable to complete the requirements of the study